Pacira BioSciences Files 8-K on Financials
Ticker: PCRX · Form: 8-K · Filed: Aug 5, 2025 · CIK: 1396814
| Field | Detail |
|---|---|
| Company | Pacira Biosciences, Inc. (PCRX) |
| Form Type | 8-K |
| Filed Date | Aug 5, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: financial-results, 8-K, sec-filing
Related Tickers: PCRX
TL;DR
Pacira BioSciences (PCRX) dropped an 8-K on Aug 5th with financial results and exhibits.
AI Summary
On August 5, 2025, Pacira BioSciences, Inc. filed an 8-K report detailing results of operations and financial condition. The filing includes financial statements and exhibits, with the company's principal executive offices located at 2000 Sierra Point Parkway, Suite 900, Brisbane, California.
Why It Matters
This 8-K filing provides investors with crucial updates on Pacira BioSciences' financial performance and operational results, impacting investment decisions.
Risk Assessment
Risk Level: low — This is a routine 8-K filing reporting financial results and does not indicate any unusual or significant risks.
Key Numbers
- 001-35060 — SEC File Number (Identifies the company's filing with the SEC.)
- 51-0619477 — IRS Employer Identification No. (Company's tax identification number.)
Key Players & Entities
- Pacira BioSciences, Inc. (company) — Registrant
- August 5, 2025 (date) — Date of Report
- 2000 Sierra Point Parkway, Suite 900, Brisbane, California 94005 (location) — Principal Executive Offices
- Pacira Pharmaceuticals, Inc. (company) — Former Company Name
- Blue Acquisition Corp (company) — Former Company Name
FAQ
What specific financial information is being reported in this 8-K?
The 8-K filing indicates it pertains to 'Results of Operations and Financial Condition' and includes 'Financial Statements and Exhibits'.
When was this 8-K report filed?
The report was filed on August 5, 2025.
What is the principal business address of Pacira BioSciences, Inc.?
The principal executive offices are located at 2000 Sierra Point Parkway, Suite 900, Brisbane, California 94005.
Has Pacira BioSciences, Inc. operated under different names previously?
Yes, the company was formerly known as Pacira Pharmaceuticals, Inc. and PACIRA INC, and prior to that, Blue Acquisition Corp.
What is the SEC Act under which this report is filed?
This report is filed under the 1934 Act.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on August 5, 2025 regarding Pacira BioSciences, Inc. (PCRX).